APA (7th ed.) Citation

MO, D. L. R., JL, L., H, R., MA, A., J, C., FM, V., . . . LM, L. (2022). Risk stratification and lipid evaluation in mexican patients, evidence of lipid and cardiovascular analysis in REMECAR. The mexican registry of cardiovascular diseases (REMECAR group). Atherosclerosis plus, 50, 32. https://doi.org/10.1016/j.athplu.2022.08.002

Chicago Style (17th ed.) Citation

MO, De Los Ríos-Ibarra, et al. "Risk Stratification and Lipid Evaluation in Mexican Patients, Evidence of Lipid and Cardiovascular Analysis in REMECAR. The Mexican Registry of Cardiovascular Diseases (REMECAR Group)." Atherosclerosis Plus 50 (2022): 32. https://doi.org/10.1016/j.athplu.2022.08.002.

MLA (9th ed.) Citation

MO, De Los Ríos-Ibarra, et al. "Risk Stratification and Lipid Evaluation in Mexican Patients, Evidence of Lipid and Cardiovascular Analysis in REMECAR. The Mexican Registry of Cardiovascular Diseases (REMECAR Group)." Atherosclerosis Plus, vol. 50, 2022, p. 32, https://doi.org/10.1016/j.athplu.2022.08.002.